These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
121 related items for PubMed ID: 18816071
1. Kinetics of antigen-antibody interactions employing a MALDI mass spectrometry immunoassay. Morrissey B, Downard KM. Anal Chem; 2008 Oct 15; 80(20):7720-6. PubMed ID: 18816071 [Abstract] [Full Text] [Related]
2. Antigenic characterisation of H3N2 subtypes of the influenza virus by mass spectrometry. Morrissey B, Streamer M, Downard KM. J Virol Methods; 2007 Nov 15; 145(2):106-14. PubMed ID: 17588679 [Abstract] [Full Text] [Related]
3. Antigenicity of a type A influenza virus through comparison of hemagglutination inhibition and mass spectrometry immunoassays. Schwahn AB, Downard KM. J Immunoassay Immunochem; 2009 Nov 15; 30(3):245-61. PubMed ID: 19591040 [Abstract] [Full Text] [Related]
4. [Peptide mapping of the monoclonal antibodies against the heavy chain hemagglutinin from influenza virus H3N2]. Mazurkova NA, Isaeva EI, Podcherniaeva RIa. Mol Gen Mikrobiol Virusol; 2006 Nov 15; (4):19-23. PubMed ID: 17094654 [Abstract] [Full Text] [Related]
6. Subtyping of the influenza virus by high resolution mass spectrometry. Schwahn AB, Wong JW, Downard KM. Anal Chem; 2009 May 01; 81(9):3500-6. PubMed ID: 19402721 [Abstract] [Full Text] [Related]
7. Epitope mapping of the gastrin-releasing peptide/anti-bombesin monoclonal antibody complex by proteolysis followed by matrix-assisted laser desorption ionization mass spectrometry. Papac DI, Hoyes J, Tomer KB. Protein Sci; 1994 Sep 01; 3(9):1485-92. PubMed ID: 7530543 [Abstract] [Full Text] [Related]
10. Antigenic surveillance of the influenza virus by mass spectrometry. Kiselar JG, Downard KM. Biochemistry; 1999 Oct 26; 38(43):14185-91. PubMed ID: 10571992 [Abstract] [Full Text] [Related]
12. A proteomics approach to survey the antigenicity of the influenza virus by mass spectrometry. Morrissey B, Downard KM. Proteomics; 2006 Apr 26; 6(7):2034-41. PubMed ID: 16502471 [Abstract] [Full Text] [Related]
14. Mass spectrometric identification of formaldehyde-induced peptide modifications under in vivo protein cross-linking conditions. Toews J, Rogalski JC, Clark TJ, Kast J. Anal Chim Acta; 2008 Jun 23; 618(2):168-83. PubMed ID: 18513538 [Abstract] [Full Text] [Related]
15. Equilibrium analysis of the interaction between a synthetic peptide of influenza virus hemagglutinin and monoclonal antibodies. McInerney TL, Nice E, Jackson DC. Biomed Pept Proteins Nucleic Acids; 2008 Jun 23; 1(1):21-4. PubMed ID: 9346865 [Abstract] [Full Text] [Related]
16. Catalytic and biochemical features of a monoclonal antibody heavy chain, JN1-2, raised against a synthetic peptide with a hemagglutinin molecule of influenza virus. Hifumi E, Takao S, Fujimoto N, Uda T. J Am Chem Soc; 2011 Sep 28; 133(38):15015-24. PubMed ID: 21861493 [Abstract] [Full Text] [Related]
17. Structurally derived mutations define congenital heart block-related epitopes within the 200-239 amino acid stretch of the Ro52 protein. Ottosson L, Salomonsson S, Hennig J, Sonesson SE, Dörner T, Raats J, Kuchroo VK, Sunnerhagen M, Wahren-Herlenius M. Scand J Immunol; 2005 Feb 28; 61(2):109-18. PubMed ID: 15683447 [Abstract] [Full Text] [Related]
18. Immunological study of HA1 domain of hemagglutinin of influenza H5N1 virus. Chiu FF, Venkatesan N, Wu CR, Chou AH, Chen HW, Lian SP, Liu SJ, Huang CC, Lian WC, Chong P, Leng CH. Biochem Biophys Res Commun; 2009 May 22; 383(1):27-31. PubMed ID: 19324009 [Abstract] [Full Text] [Related]